GlassScriptPhysician profile
Young H Choi
NPI 1780799684
$4,624.78
in general payments reported to CMS, 2019-2025
11 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.36 · 2020: $428 · 2021: $500 · 2022: $2,885 · 2023: $229 · 2024: $97.50 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729 · Gift: $36.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.66 |
| Gift | $36.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Cataract Technology INC. | $3,240.14 | 2020-2022 | |
| Alcon Vision LLC | $492.33 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Carl Zeiss Meditec, INC. | $400.00 | 2020 | |
| Rxsight INC | $282.69 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $79.64 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $36.14 | 2025 | Visumax |
| Johnson & Johnson Vision Care, INC. | $28.62 | 2023 | Acuvue |
| New World Medical,INC. | $20.56 | 2022 | |
| Bausch & Lomb Americas INC. | $20.45 | 2025 | Envista Mx60 Iol |
| Maculogix, INC. | $12.38 | 2019 | |
| Eyevance Pharmaceuticals LLC | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.